{"name":"Collaborative Neuroscience Research, LLC","slug":"collaborative-neuroscience-research-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xanomeline and Trospium Chloride","genericName":"Xanomeline and Trospium Chloride","slug":"xanomeline-and-trospium-chloride","indication":"Psychosis in Alzheimer's disease","status":"marketed"}]}],"pipeline":[{"name":"Xanomeline and Trospium Chloride","genericName":"Xanomeline and Trospium Chloride","slug":"xanomeline-and-trospium-chloride","phase":"marketed","mechanism":"Xanomeline is a muscarinic M1/M4 receptor agonist combined with trospium chloride, an anticholinergic agent, to enhance cognitive function while mitigating peripheral cholinergic side effects.","indications":["Psychosis in Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE05aVdFX3MyY2dwTVNEWnhHR2tpNDRtWXFuZ05CLVNuUEwtV0hheVdFVjFwY2FtbjlpWTJZb0lRWFdMcFZQbGhyUl9VNlBibkdmRkpURmtVMTJrbV9qMUFCS3pzUURZWjVsN2xZa0FpX3FjRkRO?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Neuroscience Market Size, Industry Share, and Forecast, 2034 - Fortune Business Insights","headline":"Neuroscience Market Size, Industry Share, and Forecast, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPeWlwUUwxbXVsTndOWWZJcE54MGNUNS10c3RFR3VKS2kzU1lHLTJVcnNLTjd1Q3FIVExRU1QwWTB1UU1vVlV3U3phSmkxc0lDS09DVkdMLWxjWTY4M0Y3YmxVdDJMcUJscGZuUW9MMmJINFNzU0wxbl9pQ1VUX1dEeUhhaFZvZmNQOG9sbjN6U3RqcDNIUmRfM282VVotakROLU1IMTZkeG9sMWltWExMVGZBd1ZlZGQ1ckxfNkJmRFVmblBKMFlvd0s0VzBtRktwS0JjX2pDaUExMFpMZjlqa2htd0E0bHFsWHUxN3QyM1E5UlphS2hTU29GZFk0VzdqUXVmY0xvUlRKdlB4OWc?oc=5","date":"2026-03-04","type":"deal","source":"GlobeNewswire","summary":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewswire","headline":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNYTE5UDhqNXdYS2RMLVoxTjRTdnhnSE5RajFEa1YtQXF5UC14NDRyM003NC02Wm5GZFJUWVBnN00yVVA0UlpGYzl5REp4MG1HWlU0YlMxSzBxRHZYazFfVTFHNDZoZldMNUVCTEZxMzdIQnRNazNYUWU0c3Q5TEZOdFVvQmZfT0JCLVN0UktFbHVVeDJfLTBtX3BvMHhORko2eG5OWTlxc3pFTzE1R3lPYTlVYzFxVnJyUXRWQ0Q5SVJ2eGptQVR3cG5oaGVWOG1ucXRUend0dkpwYXVFTTZnS2VwTEtXLVk?oc=5","date":"2026-02-03","type":"deal","source":"GlobeNewswire","summary":"Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire","headline":"Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPQzBST2dGb2FrRUF5SjZST01vbUgxa1E5c2V6MG0taUVDcUNvV3FMeld2V1N0N2p0Rk1TbFVNR3duZUE5d0dyMGhUU202OUhVTUY2dU56WS1Qb09aNFZabFJnY0tlaHVDRHR5OVEyTEltT29rOWV5N2Q3SkExdkw5UjZVZ2Zyb2FZR3o2VGszaE1ESFBrVmhoYm0yNUtNd0xRMGc?oc=5","date":"2026-01-12","type":"pipeline","source":"Fierce Biotech","summary":"Novartis pays SciNeuro $165M for ticket on another shuttle to brain - Fierce Biotech","headline":"Novartis pays SciNeuro $165M for ticket on another shuttle to brain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNaTJUWnBOYlVJX2ptRjY4WUd6X0d5YW1uT3pCSjNXWllXdEJRQVhrT2x0bXZSa3lsQ3l2RGgtSmxBU2pTOGhJckoxRzRacXNOMDk2VnhNLTRRZzUtRC03Q1pudkp2NVY4LXFBS05Sa1ZZWlU0dHVoSk5VM3J3elpRU3V6Y09PZ19GYkxnanVrLVhYZWtGS3FyM3o4Tkszbm5w?oc=5","date":"2026-01-12","type":"pipeline","source":"BioWorld News","summary":"Keiferx collaborates with Amneal on KFRX-06 for Parkinson’s - BioWorld News","headline":"Keiferx collaborates with Amneal on KFRX-06 for Parkinson’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQR3BYRWRNbVJfWmxVb2NDNHAxcld0ckFwTklyS05idXhNb1N4VFluNUJmNFJOOGtXS1dqN1dVQzkwS2xOZ1M5ZHVJeUJtTDBybllNRGs3RXlLeEh4Q0xFaThtN2MyNG5SM2VzVHdWY0dZRVhpMmpDVEhNV0J0T1ItZ3FSM2hHbGZ2TTIyYkdfUEpNTktPV3laSzdPV2E3NUt3cnBaSQ?oc=5","date":"2025-11-13","type":"pipeline","source":"Fierce Biotech","summary":"UPDATED: AbbVie to end Calico collab after 11-year run, plans layoffs: Stat - Fierce Biotech","headline":"UPDATED: AbbVie to end Calico collab after 11-year run, plans layoffs: Stat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE4yOHQ0OE1pWUN3WXdPMzIzTlRnZkVsdm9KNml0Tkg3Ulk0NUNfZmJXVFgyaEh4NnlBdGdyLW05b1dkOE9IRUpDYXpsYUUwSGtfbkw0QnF5cDJZT2t6YlhRWVd3?oc=5","date":"2025-09-04","type":"pipeline","source":"Fierce Pharma","summary":"Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research - Fierce Pharma","headline":"Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQUEZLaWJZZEw5UWwxNnFzbVdvWU9XTE9vcUxUZ2dqajcwU3czY052RXY2NHhxSmc4VkYxYW5uN2prNGJuc2NjcldHdU56aVVyVTdvZ2RzRFVpRVp6WldHd0xzMElFMDZ1anZpYWw1MHhuQXhDZlF5Z2JlcENLZ0ZGMWtUYy1WekpqWHNBeDdFVGpaa3dnNXUtbkFIZ2x0V2p3QTlVNlVkUzRicUhJb3ZGOV9nMVdFejNSRG94aGR4eGE1RGwtVXhkaQ?oc=5","date":"2025-09-02","type":"deal","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Arrowhead Pharmaceutica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQSmltblRYUW82S0ROZFNjY09xYzFlVDc5NTVCTnZqNThvVFNKOXFBdnd4b3pWSzFBSDlyUzk1X0xhRUZWZVBmbklCUlY0ZjNOd1ViOGZPc0VJeXBNYU5Genl4QWd6dDV3SlR6OEJoVzZqeUwtbzJCRDRIMTZsMjRrb1lkUGpWaVpEaVFQOVVkUS1fTUN1VHRhbk0xcjhIVXhJM0VmdFc2ZXVKbVBOMWtoWWFiQ0x1X1NCTnFvTTE0NGp6R3VGcW9xT1d4TjlTdGtlZmdyajZxU052ZUdOZjYxTFUzTFViUQ?oc=5","date":"2025-09-02","type":"deal","source":"businesswire.com","summary":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - businesswire.com","headline":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNUzFhYmRHSWpUa1prRGdvZTNyVFNWRHoxSzdOV1FhZGdfVnZaeVhLUm11VUlxUGp4V3BXeXUySGd4MzQ5dGpNS2JXbnY4clhPSWRXSE9ZNDVpZHl0ajBVRzFrS0JkUUxIcjJHNldjVXJJMDBsYUlPNzlONXpXR1E0NXFjVzhOWkVac2ljQzhvdzFXT0FMczRNb19qV3hDdkFCTTd1cjJRNFdNT3YxenBQNzRIa3d6bGJTTThlbU4xS2Qyck5remNXZG9PVDB5Y3NRZFEzYURGUEhCQlprOFlqLWhlOGdqNGtGT24xVzVEY3JJYVdQSktoWklzbWFJUmh4cndrbmJJR0xrYlh2MWhpTzB3SVYxbENVMnFmSWRwZFhMc2s?oc=5","date":"2025-08-06","type":"trial","source":"Psychiatrist.com","summary":"Rapid Onset and Sustained Efficacy of Onfasprodil (MIJ821), a Novel NR2B Negative Allosteric Modulator, in Patients With Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proo","headline":"Rapid Onset and Sustained Efficacy of Onfasprodil (MIJ821), a Novel NR2B Negative Allosteric Modulator, in Patients With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5UZVljRlZwUGk3akczaFltOFd5WGYxeWp2Rk1PQy11Z3lfRTlMdDRPemIwSWNTMzE1cDN0bWltSmN5NVpiY2tHRWRDTFFtcWhUbXpHS0FfUU0xS0Zi?oc=5","date":"2024-12-18","type":"pipeline","source":"EurekAlert!","summary":"Davos Alzheimer’s Collaborative and pharmaceutical and diagnostics companies work together on Alzheimer’s disease blood biomarker validation - EurekAlert!","headline":"Davos Alzheimer’s Collaborative and pharmaceutical and diagnostics companies work together on Alzheimer’s disease blood ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMzFCN3dkOTlzRWoxRk5ZbWJObmU5TXpzb2FCQ2lYTFBBV25UU0hCejBxc1psaUxFR2sydl9JZXc0QW9IWnhpVTczbUp4WVd3b08xLUNmNnFaYWtjcFRMVlMxanI5aTNvVzBBRUN3VmhfUnJWR190c1BKWGU2Tk91eExENC1hRVZ1c0ZrQnpEeUZsanBKYUdPd1l0bUM?oc=5","date":"2022-06-16","type":"pipeline","source":"drugdiscoverytrends.com","summary":"CenExel purchases Apex Innovative Sciences - drugdiscoverytrends.com","headline":"CenExel purchases Apex Innovative Sciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}